ππ»ππ ±οΈπ ΄π °ππ Έππ ·π π»ββοΈ π
π―π»π― Modernaβs Last Stand: Churchill Chair Pattern in Play β Could MRNA Hit Zero? π―π»π―
Kia ora Tiger traders! Today, weβre zooming in on Moderna Inc. ($MRNA), facing a potential downward spiral with a unique βChurchill Chairβ pattern (see the chart below ππ»). Are we witnessing the beginning of the end for this biotech giant, or is there still some life left?
π Latest Numbers & Performance Rundown:
β’ Current Price: $41.64, showing a steady decline (-1.19%)
β’ 52-Week Range: High $170.47, Low $40.24 β weβre hanging just above rock-bottom levels!
β’ PE Ratio: Not looking good, with a Forward PE projection at a surprising -4.51
β’ EPS Forecast: Grim projections ahead: $-9.23 for 2024, with slightly improved yet negative numbers through 2026
π§ Key Levels to Watch:
β’ Support: $40.24 β if we break through here, the drop could intensify!
β’ Resistance: 50-Day MA at $84.72 β thatβs a long climb from current levels, but never say never in this market.
ποΈ Analyst Sentiment & Ratings:
β’ π΄ Sell: 8%
β’ π‘ Hold: 58%
β’ π’ Buy: 31%
β’ With only 4% on Strong Buy, analysts are clearly cautious about this stock. π» Hedge funds are eyeing MRNA as a risky play, echoing Churchillβs βnever surrenderβ for the bears.
π Capital Flow Insight:
Capital has been flowing OUT of Moderna, signalling that big money might be looking for greener pastures. For short-term traders, this could mean more bearish pressure ahead!
π₯ Fun Historical Comparison:
Remember BlackBerry ($BB)? It soared during its prime, only to nosedive when competition ramped up and innovation stalled. Moderna could be treading a similar path ~ will it reinvent, or could it remain a cautionary tale?
π€ Analyst Quote:
βModernaβs decline mirrors Churchillβs infamous chair β stable for now but precarious without innovation. Bulls are holding their breath for a pivot; bears are counting on more drops.β β Wall Street Veteran
πͺ βChurchill Chairβ Pattern Breakdown:
This pattern is a tough seat for Moderna investors! Without new innovation or positive capital flow, MRNA may keep sliding, inching closer to zero. For pattern traders like me, this setup screams βcautionβ and has us eyeing PUTS for potential gains.
π Hedge Play: For a lower-cost bear approach, consider a bear put spread β buy a $40 put and sell a $30 put with the same expiration. This limits your premium but lets you profit from a downside move!
π₯ High-Risk, High-Reward: The Churchill Chair isnβt for the faint-hearted! If MRNA keeps dropping, the bears might just pop the champagne! πΎπ»
Hey Tiger Traders, if MRNA goes into freefall, where do you see the next support level β $35 or a shocking dip below $30? π§
TigerGPT, what other companies have shown the βChurchill Chairβ pattern, and how did they fare afterward?
Happy trading ahead. Cheers, BC πππ
@Tiger_comments @TigerStars @TigerPicks @TigerPM @TigerWire @Daily_Discussion @TigerGPT
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
As a professional financial analyst, let's analyze Moderna Inc. ($MRNA) and compare it to Pfizer Inc. and Johnson & Johnson in terms of the "Churchill Chair" pattern and their performance afterwards.
Business Overview and Industry Growth:Moderna Inc. is a biotechnology company specializing in the development and commercialization of messenger RNA (mRNA) therapeutics and vaccines. The company has gained significant attention due to its involvement in the development of COVID-19 vaccines. The mRNA technology has potential applications in various areas of medicine, indicating future growth opportunities in the biotech industry.
Earnings and Forecast:Moderna's latest earnings forecast is grim, with a projected EPS of -$9.23 for 2024. The company is expected to have negative numbers through 2026. This reflects the challenges and uncertainties in the biotech industry. In comparison, Johnson & Johnson is projected to have a forecasted EPS of $9.95 for 2024, with positive growth in subsequent years.
Support and Resistance Levels:Moderna's current support level is at $40.24, and if it breaks through this level, the drop could intensify. The resistance level is at the 50-Day Moving Average of $84.72, indicating a long climb from current levels.
Analyst Sentiment and Ratings:Analysts' sentiment towards Moderna is cautious, with only 4% on Strong Buy, 31% on Buy, 58% on Hold, and 8% on Sell. This indicates a mixed outlook for the stock. Hedge funds are also closely monitoring Moderna's performance, suggesting a high level of interest among traders.
"Churchill Chair" Pattern and Hedge Plays:The "Churchill Chair" pattern suggests caution for Moderna investors. Without new innovation or positive capital flow, the stock may continue to slide, possibly approaching zero. For pattern traders, this setup indicates potential opportunities using bearish strategies like bear put spreads.
Comparison to Pfizer Inc. and Johnson & Johnson:While Moderna's performance is unique, it's worth comparing it to other major players in the biotech industry. Pfizer Inc. is a pharmaceutical company known for its COVID-19 vaccine and has been relatively stable. Johnson & Johnson, a well-established healthcare conglomerate, has a positive earnings outlook and a more diversified business portfolio. It's important to consider the specific circumstances and factors affecting each company when making investment decisions.
Please note that the above analysis is for informational purposes only and should not be considered as investment advice. The stock market is subject to inherent risks and fluctuations, and investors should conduct their own research and analysis before making any investment decisions.
Stay informed and think independently before making any investment choices.
Great article, would you like to share it?
Great article, would you like to share it?
Great article, would you like to share it?
Great article, would you like to share it?
Great article, would you like to share it?